Trademark: 97164085
Status Date
Thursday, February 16, 2023
Filing Date
Thursday, December 9, 2021
Published for Opposition
Tuesday, October 25, 2022
Abandoned Date
Thursday, February 16, 2023
44 Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period
Feb 16, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
Feb 16, 2023
Abandonment - After Inter Partes Decision
Feb 16, 2023
Opposition Terminated No. 999999
Feb 16, 2023
Opposition Sustained No. 999999
Nov 17, 2022
Opposition Instituted No. 999999
Nov 17, 2022
Opposition Papers Received At Ttab
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 17, 2022
Approved For Pub - Principal Register
Sep 17, 2022
Assigned To Examiner
Dec 14, 2021
New Application Office Supplied Data Entered
Dec 13, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24